Unlike other antiviral drugs, zanamivir is administered as an inhalation powder using a device called a Diskhaler. This mode of administration allows the drug to be delivered directly to the respiratory tract, where the influenza virus primarily replicates. This localized delivery helps to maximize the drug's efficacy while minimizing systemic side effects.
